141713-95-3

Upstream product

• 55516-54-6 L-1-naphthylalanine 
• 141714-15-0 (S)-methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-(naphthalen-1-yl)propanamido)hexanoate 
• 118741-06-3 (4S,5S)-4-Isobutyl-2,2-dimethyl-5-{(E)-2-[(pyridin-4-ylmethyl)-carbamoyl]-but-1-enyl}-oxazolidine-3-carboxylic acid benzyl ester 
• 118741-15-4 (4S,5S)-5-((E)-2-Ethoxycarbonyl-but-1-enyl)-4-isobutyl-2,2-dimethyl-oxazolidine-3-carboxylic acid benzyl ester 
• 65365-15-3 2S-2-benzyloxycarbonylamino-2-(naphth-1-yl)methyl-acetic acid 
• 59759-78-3 2-benzoylamino-3-naphthalen-1-yl-propionic acid 
• 3731-53-1 4-(aminomethyl)pyridine 
• 118586-12-2 N--L-norleucine 

Relevant academic research and scientific papers

Renin inhibitors. I. Synthesis and structure-activity relationship of transition-state inhibitors containing homostatine analogues at the scissile bond

The synthesis and structure-activity relationships of transition-state renin inhibitors containing the homostatine analogues at the scissile bond are described. These inhibitors incorporate the amino acid side chains corresponding to positions 7-12 (Psub